|
시장보고서
상품코드
2050853
소화기계 약물 시장 : 유형별, 약제 클래스별, 투여 경로별, 용도별, 유통 채널별 및 지역별Digestive Drugs Market, By Type, By Drug Class, By Route of Administration, By Application, By Distribution Channel, And by Region |
||||||
가격
※ 부가세 별도
한글목차
영문목차
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.
소화기계 약물 시장은 2026년에 661억 7,480만 달러로 추정되며, 2033년까지 998억 9,730만 달러에 이를 것으로 예상되고 있습니다. 또한 2026-2033년 CAGR 6.1%를 기록할 전망입니다.
| 보고서 범위 | 보고서 상세 | ||
|---|---|---|---|
| 기준 연도 : | 2025년 | 2026년 시장 규모 : | 661억 7,480만 달러 |
| 과거 데이터 기간 : | 2020-2024년 | 예측 기간 : | 2026-2033년 |
| 예측 기간(2026-2033년) CAGR : | 6.10% | 2033년 시장 규모 예측 : | 998억 9,730만 달러 |
소화기계 약물은 위산 역류, 소화불량, 과민성 대장 증후군(IBS) 등의 위장 증상을 완화하는 데 사용됩니다. 또한, 크론병, 궤양성 대장염, 식도열공탈장 등 심각한 질환의 치료에도 사용됩니다. 일반적인 소화기 질환에는 복통, 복부 팽만감, 설사, 변비, 속쓰림 등의 증상이 포함됩니다. 다양한 위장 질환의 치료에는 다양한 위장 치료제가 사용되고 있습니다. 예를 들어, 위산 역류나 소화불량에는 라니티딘이나 오메프라졸과 같은 제산제가 사용됩니다. 반면 궤양성 대장염이나 크론병과 같은 더 심각한 질환에는 부데소니드, 메살라진, 프레드니솔론 등의 약물이 사용됩니다. 소화기계 약물을 제조하는 주요 시장 기업으로는 애브비, 알렉시온 파마슈티컬스, 글락소 스미스클라인, 아이언우드 파마슈티컬스, 얀센 파마슈티컬스 등이 있습니다.
시장 역학
소화기계 약물 시장에서 사업을 영위하는 기업들은 신약을 출시하고 있으며, 이는 시장 성장에 기여하고 있습니다. 예를 들어, 2022년 7월 국내 제약사 JW중외제약은 복합 소화기 치료제 '베스티콘'을 출시했습니다. 본 제품은 알베린 구연산염, 시메티콘 및 진경제로 구성되어 있습니다. 베스티콘은 과민성대장증후군, 소화불량, 기타 위장장애를 앓고 있는 환자에게 효과적입니다. 마찬가지로 2022년 5월, 다국적 제약사 브리스톨 마이어스 스퀴브(Bristol-Myers Squibb)가 중증 활동성 궤양성 대장염(UC) 치료제 '제포시아'에 대해 미국 식품의약국(FDA)의 승인을 받았습니다. 스핑고신 1-인산(S1P) 수용체 조절제이며, 장내 림프구의 침윤을 억제하는 역할을 합니다.
본 조사의 주요 특징
- 이 보고서는 다양한 부문의 잠재적 수익 창출 기회를 밝히고, 이 시장의 매력적인 투자 제안 매트릭스를 설명합니다.
- 또한 시장 성장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업의 경쟁 전략에 대한 중요한 인사이트를 제공합니다.
- 이 연구는 다음과 같은 매개 변수를 기반으로 세계 소화기계 약물 시장의 주요 기업 프로파일을 작성합니다. 기업 하이라이트, 제품 포트폴리오, 주요 하이라이트, 재무 성과, 전략.
- 세계 소화기계 약물 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 시장 진출기업, 재무 분석가 등 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 세계 소화기계 약물 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 쉽게 내릴 수 있을 것입니다.
목차
제1장 조사 목적과 전제조건
제2장 시장 전망
제3장 시장 역학, 규제 및 동향 분석
제4장 세계의 소화기계 약물 시장 : 유형별, 2026년-2033년
제5장 세계의 소화기계 약물 시장 : 약제 클래스별, 2026년-2033년
제6장 세계의 소화기계 약물 시장 : 투여 경로별, 2026년-2033년
제7장 세계의 소화기계 약물 시장 : 용도별, 2026년-2033년
제8장 세계의 소화기계 약물 시장 : 유통 채널별, 2026년-2033년
제9장 세계의 소화기계 약물 시장 : 지역별, 2026년-2033년
제10장 경쟁 구도
제11장 섹션
LSH 26.06.12Digestive Drugs Market is estimated to be valued at USD 66,174.8 Mn in 2026 and is expected to reach USD 99,897.3 Mn by 2033, growing at a compound annual growth rate (CAGR) of 6.1% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 66,174.8 Mn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 6.10% | 2033 Value Projection: | USD 99,897.3 Mn |
Digestive drugs are used to relieve gastrointestinal symptoms such as acid reflux, indigestion, and irritable bowel syndrome (IBS) among others. In addition, it is also used to treat other severe conditions such as Crohn's disease, ulcerative colitis, and hiatal hernia. The common digestive system diseases include symptoms such as abdominal pain, bloating, diarrhoea, constipation and heartburn. There are various gastrointestinal therapeutics that are used for treating various gastrointestinal conditions. For instance, acid reflux and indigestion are treated with antacids such as ranitidine and omeprazole. More severe conditions like ulcerative colitis and Crohn's disease are treated with medications such as budesonide, mesalazine and prednisolone. Few key market players manufacturing gastrointestinal drugs includes AbbVie, Alexion Pharmaceuticals, GlaxoSmithKline, Ironwood Pharmaceuticals and Janssen Pharmaceuticals among others.
Market Dynamics
Companies operating in digestive drugs market are launching new drugs which is contributing to growth of the digestive drugs market. For instance, in July 2022, JW Pharmaceutical, a South Korea based pharmaceutical company, launched Besticon a compound digestive medicine. It is composed of alverine citrate, simethicone and antispasmodic agent. Besticon is effective for patients suffering with irritable bowel syndrome, indigestion and other gastrointestinal issues. Similarly, in May 2022, Bristol Myers Squibb, a multinational pharmaceutical company received the U.S. Food and Drug Administration (FDA) approval for Zeposia for the treatment of severely active ulcerative colitis (UC). It is a sphingosine 1-phosphate (S1P) receptor modulator which reduces lymphocyte migration into the intestines.
Key features of the study
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global digestive drugs market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, strategies
- Key companies covered as a part of this study include GlaxoSmithKline plc, AbbVie Inc. (Allergan), Takeda Pharmaceutical Company Limited, Pfizer Inc, AstraZeneca plc, Marksans Pharma, Tillotts Pharma AG, Salix Pharmaceuticals, Otsuka Pharmaceutical Co., Ltd., Merck & Co., Inc., Lexicon Pharmaceuticals, Inc., Bayer AG, Cadila Healthcare Ltd.
- Global digestive drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have an ease in decision-making through various strategy matrices used in analyzing the global digestive drugs market
Market Segmentation
- Global Digestive Drugs Market, By Type (Revenue, USD Mn, 2021 - 2033)
- Branded
- Generic
- Global Digestive Drugs Market, By Drug Class (Revenue, USD Mn, 2021 - 2033)
- 5-aminosalicylates
- GI stimulants
- Laxatives
- Antacids
- H2 Antagonists
- Antidiarrheals
- Others
- Global Digestive Drugs Market, By Route of Administration (Revenue, USD Mn, 2021 - 2033)
- Oral
- Intravenous
- Others
- Global Digestive Drugs Market, By Application (Revenue, USD Mn, 2021 - 2033)
- Gastroesophageal Reflux Disease (GERD)
- Irritable Bowel Syndrome
- Ulcerative Colitis
- Others (Chronic diarrhoea, constipation etc.)
- Global Digestive Drugs Market, By Distribution Channel (Revenue, USD Mn, 2021 - 2033)
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Global Digestive Drugs Market, By Region (Revenue, USD Mn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Digestive Drugs Market Companies
- GlaxoSmithKline plc
- AbbVie Inc. (Allergan)
- Takeda Pharmaceutical Company Limited
- Pfizer Inc
- AstraZeneca plc
- Marksans Pharma
- Tillotts Pharma AG
- Salix Pharmaceuticals
- Otsuka Pharmaceutical Co., Ltd.
- Merck & Co., Inc.
- Lexicon Pharmaceuticals, Inc.
- Bayer AG
- Cadila Healthcare Ltd.
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Type
- Market Snapshot, By Drug Class
- Market Snapshot, By Route of Administration
- Market Snapshot, By Application
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Opportunity
- Impact Analysis
- Key Developments
- Regulatory Scenario
- Market Trends
- New Product Launches
- Regulatory Scenario
- PORTER's Five Forces Analysis
- Business Development Strategies
- Epidemiology
- Disease Awareness Programs
- Treatment Safety and Efficacy Analysis
- Pipeline Analysis
4. Global Digestive Drugs Market, By Type, 2026 - 2033, (US$ Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2026 - 2033
- Segment Trends
- Branded
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Mn)
- Generic
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Mn)
5. Global Digestive Drugs Market, By Drug Class, 2026 - 2033, (US$ Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2026 - 2033
- Segment Trends
- 5-aminosalicylates
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Mn)
- GI stimulants
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Mn)
- Laxatives
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Mn)
- Antacids
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Mn)
- H2 Antagonists
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Mn)
- Antidiarrheals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Mn)
6. Global Digestive Drugs Market, By Route of Administration, 2026 - 2033, (US$ Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2026 - 2033
- Segment Trends
- Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Mn)
- Intravenous
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Mn)
7. Global Digestive Drugs Market, By Application, 2026 - 2033, (US$ Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2026 - 2033
- Segment Trends
- Gastroesophageal Reflux Disease (GERD)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Mn)
- Irritable Bowel Syndrome
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Mn)
- Ulcerative Colitis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Mn)
- Others (Chronic diarrhoea, constipation etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Mn)
8. Global Digestive Drugs Market, By Distribution Channel, 2026 - 2033, (US$ Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2026 - 2033
- Segment Trends
- Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Mn)
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Mn)
- Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Mn)
9. Global Digestive Drugs Market, By Region, 2026 - 2033, (US$ Mn)
- Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Regions, 2026 - 2033
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2026 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2026 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2026 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (US$ Mn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2026 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2026 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2026 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (US$ Mn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2026 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2026 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2026 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (US$ Mn)
- U.K.
- Germany
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2026 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2026 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2026 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (US$ Mn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2026 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2026 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2026 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (US$ Mn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2026 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2026 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2026 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2026 - 2033, (US$ Mn)
- North Africa
- Central Africa
- South Africa
10. Competitive Landscape
- Market Share Analysis
- GlaxoSmithKline plc
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- AbbVie Inc. (Allergan)
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Takeda Pharmaceutical Company Limited
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Pfizer Inc
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- AstraZeneca plc
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Marksans Pharma
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Tillotts Pharma AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Salix Pharmaceuticals
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Otsuka Pharmaceutical Co., Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Merck & Co., Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Lexicon Pharmaceuticals, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Bayer AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Cadila Healthcare Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- GlaxoSmithKline plc
- Analyst Views
11. Section
- Research Methodology
- About us
